recent consolidated financial statements of the Company for the 3-month period ending 31 March 2018. As a result, the Company is obliged to seek approval from the Board of Directors and disclose
value of consideration basis. The highest transaction value is derived from this method of calculation, whereby the, calculation is based on the Company’s reviewed consolidated financial statements for
position for the first quarter ended March 31, 2019 with those of 2018. This report discusses principal changes in the unreviewed consolidated financial statements. Overall market environment The Thai
Indorama Ventures Public Company Limited for second quarter ended June 30, 2019 We are pleased to submit: 1. Consolidated and Company only Quarterly Review of Financial Statements for for the second quarter
According to the resolution of the meeting of the Board of Directors No. 5/2017 of Rajthanee Hospital Public Company Limited (the “Company”) held on 11 Aug 2017, approving the reviewed consolidated financial
Exchange of Thailand The Board of Directors Meeting of Wattanapat Hospital Trang Public Company Limited (the “Company”) No. 3/2017, held on February 26, 2017, approving the audited consolidated financial
has been reviewed by the auditor of the company and with the following results. The Company's performance for the second quarter of 2020 for the Company's consolidated financial statements The Company
Ventures Public Company Limited for the first quarter of 2019 We are pleased to submit: 1. Consolidated and Company only Quarterly Review Financial Statements for the first quarter of 2019 (a copy in Thai
Indonesia result since 4Q18. IVL has 100% ownership since January 3rd, 2019 Indorama Ventures 1st Quarter 2019 MD&A 16 Table 10: IVL Consolidated Statement of Income 1 As per internal classification and